Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like GlaxoSmithKline Ditches Ionis Pharma's Inotersen and IONIS-FB-LRx August 10, 2017 Gene Therapy Firm Files for $35 Million IPO August 21, 2017 Why Pfizer Could and Should Scoop Up Celgene in 2018 December 4, 2017
